Vland Biotech
60373911.261.26% ( +0.14 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Vland Biotech(603739) the Revenue is 345.05 M (+11.24%);the EBIT is 28.5 M (+4.93%);the EPS is 0.07 (+75%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.35B11.24%
----
----
EBIT
0.03B4.93%
----
----
EPS
0.0775.00%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf